ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281613; 2) Community: the network communities that were significantly associated with the response to NSC 281613; 3) Molecule: the relationships between components within communities and NSC 281613; 4) MDR: the compounds that were significantly associated with the NSC 281613.

NSC Compound Enrichment Correlation
NSC 709564 Null 0.00411343439683528 0.13090993
NSC 710779 Null 0.00411343439683528 0.076471361
NSC 726328 3-Bromo-4-(3,3-dimethyl-but-1-ynyl)-2(5H)-furanone 0.00411343439683528 -0.08884777
NSC 728132 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene 0.00411343439683528 0.0081898927
NSC 743556 Null 0.00411343439683528 0.046130628
NSC 757948 (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-methoxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.00411343439683528 -0.23725848
NSC 116878 Cardiac glycoside 0.00414350254426684 0.31355545
NSC 123978 Sarveroside 0.00414350254426684 0.47631368
NSC 274548 Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- 0.00414350254426684 0.084635113
NSC 603831 Acteoside 0.00414350254426684 0.23061919
Total:61  Current:7    [First] [Prev] [Next] [Last]